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Abstract  This  case  report  describes  the  variations  in  visual  performance  of  a  subject  with
moderate  keratoconus  with  changes  in  front  surface  eccentricities  (FSEs)  of  PROSE  (Prosthetic
Replacement  of  Ocular  Surface  Ecosystem).  PROSE  device  of  0.6  FSE  provided  maximum  visual
improvement  and  reduction  in  Higher  Order  Aberrations  (HOAs)  compared  to  0,  0.3  and  0.8  FSEs
in this  clinical  condition.
©  2013  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Rendimiento  visual  con  cambios  de  excentricidad  en  el  dispositivo  PROSE:  informe  de
un  caso
Resumen  Este  informe  de  un  caso  describe  las  variaciones  del  rendimiento  visual  de  un
paciente  con  queratocono  moderado  con  cambios  de  las  excentricidades  de  la  superﬁcie  frontalsuperﬁcie  frontal
(ESF) de  PROSE  (Sustitución  protésica  del  ecosistema  de  la  superﬁcie  ocular).  El  dispositivo
PROSE de  0,6  ESF  aportó  una  mejora  visual  máxima  y  una  reducción  de  las  aberraciones  de
orden superior,  en  comparación  a  ESF  de  0,  0,3  y  0,8  en  esta  situación  clínica.
© 2013  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.  Todos  los
derechos reservados.∗ Corresponding author at: Elite School of Optometry, Unit of
edical Research Foundation, Chennai, Tamil Nadu, India.
E-mail address: d.jaggu@gmail.com (D. Jagadeesh).
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eratoconus  (KC)  is  a  bilateral,  asymmetric,  corneal  disorder
hat  results  in  progressive  thinning,  steepening,  irregular
stigmatism,  and  potentially  scarring.1 PROSE  device  for-
erly  known  as  Boston  Scleral  lens  is  a  prosthetic  device
hich  resembles  transparent  domes  vaulting  the  dam-
ged  cornea  and  resting  on  the  sclera.2 PROSE  device
etry. Published by Elsevier España, S.L. All rights reserved.
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RVisual  performance  with  changes  in  eccentricity  in  PROSE  de
maintains  stable  ocular  surface  environment,  masks  the
corneal  irregularity  and  thereby  enhances  vision  in  Irregular
corneal  conditions.2--4
Irregular  corneal  conditions  gives  rise  to  HOA  like  coma,
spherical  aberrations,  trefoil  and  tetra  foil  creating  visual
disturbances  or  symptoms  like  shadowing,  starbursts,  ghost
images,  reduction  in  contrast  sensitivity  and  distorted  night
vision.5,6 Use  of  FSE  in  PROSE  device  has  shown  to  reduce  the
HOA  and  thereby  improve  the  visual  performance  in  subjects
with  Irregular  corneas  and  Ocular  Surface  disorders.7
This  case  demonstrates  the  clinical  impact  of  different
eccentricities  of  the  PROSE  device  on  aberrations  and  visual
performance.
Case report
A  15-year-old  female  subject  suffering  from  bilateral  kera-
toconus  presented  with  complaint  of  gradual  diminution  of
vision  in  right  eye.  The  best  corrected  visual  acuity  was  6/12
with  a  rigid  gas  permeable  corneal  lens.  Further  examina-
tions  conﬁrmed  severe  keratoconus  with  vogt’s  striae  and
apical  scarring  in  right  eye  and  healed  acute  hydrops  in
left  eye.8 The  keratometric  reading  was  63.50  @139/72.37
diopters  and  was  unobtainable  for  the  left  eye.  The  subject
was  recommended  for  PROSE  device  trial.
The  initial  trial  was  performed  to  achieve  an  optimal
ﬁtting  characteristic  which  includes  an  adequate  vault,  a
clear  front  surface  with  no  haptic  compression,  no  edge
lift  and  no  impingement  staining.  In  a  clinical  set  up,  the
availability  of  devices  with  varying  eccentricities  with  other
speciﬁcations  being  constant  is  a  rare  scenario.  Since  for
this  particular  subject  devices  of  all  FSEs  0,  0.3,  0.6  and  0.8
were  available  with  the  other  parameters  being  constant,
PROSE  device  with  different  FSE  was  tried  on  the  subject  to
observe  the  trend  in  visual  performance  and  aberrations.
PROSE  device  speciﬁcations  include  the  vault,  diameter,
base  curve,  power,  eccentricity  and  the  haptic  measure-
ments.  The  device  speciﬁcations  optimal  for  the  right  of  the
patient  was  5.3  vault,  base  curve  7.90,  power  0.01,  diam-
eter  19.5  and  14.00  haptic.  All  the  devices  had  the  same
parameters  except  the  FSE,  which  varied  as  0,  0.3,  and  0.6
and  0.8.
Best  corrected  high  contrast  visual  acuity  (HCVA)  90%  and
low  contrast  visual  acuity  (LCVA)  10%  were  recorded  using
logmar  chart  and  aberration  using  Complete  Ophthalmic
Analysis  System  Wave  front  Aberrometer  (COAS-HDTM Model
2800,  WaveFront  Sciences,  Inc.,  Albuquerque,  USA).  The
aberrometric  measurements  were  performed  with  PROSE
device  in  situ  under  scotopic  conditions  with  natural  pupil
size  above  6.0  mm.
HCVA  was  found  to  be  0.2  logmar  units  which  were  similar
with  0,  0.3  and  0.6  FSE  while  it  was  reduced  to  0.3  logmar
units  with  0.8  FSE.  LCVA  was  0.4  logmar  units  with  0.3  and
0.6  FSE.  HCVA  and  LCVA  with  the  device  of  0.3  FSE  was
0.2  logmar  units  and  0.4  logmar  units  respectively.  A  drop  in
LCVA  by  2  lines  was  observed  with  device  of  0  and  0.8  FSE.
In  this  case,  as  FSE  increased  HOAs  also  increased  except
trefoil.  Even  though  an  increase  in  horizontal  trefoil  was
observed  with  device  of  0.3  FSE,  there  was  a  reduction  of
vertical  trefoil.  The  total  trefoil  however  seems  to  decrease
with  0.6  FSE.:  A  case  report  109
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s  the  goal  of  ﬁtting  PROSE  was  to  derive  a  device  that
rovided  maximum  achievable  visual  acuity,  this  clinical
valuation  with  different  FSE  in  PROSE  with  other  param-
ters  being  constant  was  planned.
A  previously  done  case  series  which  assessed  effects  of
ifferent  optic  asphericities  on  keratoconus  subjects  showed
ixed  results.9 In  a  group  of  5  patients  ﬁtted  with  Boston
cleral  lens,  some  of  them  showed  a  drop  in  HCVA,  BCVA  and
CVA  while  HCVA  and  BCVA  increased  in  others.  In  other  study
he  Impact  of  Boston  Scleral  lenses  and  spectacles  on  HOA
as  compared.  This  study  showed  reduction  in  HOA  when
SE  of  0.6  was  induced.7 A  difference  in  visual  performance
as  also  noted  in  subjects  with  corneal  scarring  with  changes
n  FSE.10
The  visual  disturbances  arising  due  to  increase  in  HOA
ave  considerable  impact  on  subjects’  daily  living.11 These
OAs  can  be  explained  as  a  result  of  differences  in  shape
actor  due  to  the  corneal  irregularity  and  possible  changes
n  the  ﬁrst  refractive  surface  due  to  the  change  in  optics
ith  different  type  of  lenses.  Present  literature  shows  lack
f  adequate  study  with  posterior  corneal  surface  and  PROSE
evice  although  a  study  done  in  Japan  showed  that  poste-
ior  corneal  surface  also  had  an  impact  on  HOA  in  a  group
f  keratoconic  subjects.  The  study  explained  that  HOA  on
nterior  corneal  surface  was  three  to  four  times  larger  than
osterior  surface.12
In  this  case,  PROSE  device  with  FSE  of  0.3  and  0.6  provides
ptimal  HCVA  and  LCVA.  The  subject  was  prescribed  with  a
evice  of  0.6  FSE  considering  the  visual  performance  and
ubjective  assessments  of  comfort  and  glare.
onclusion
his  case  illustrates  the  potential  of  PROSE  device  with
SE  to  improve  low  contrast  acuity  when  compared  to  a
evice  without  FSE  in  moderate  keratoconus.  The  results
ould  help  in  initial  trial  lens  selection,  considerably  reduce
he  chair  time  and  thereby  guide  in  prescribing  appropri-
te  FSE  in  irregular  corneal  conditions.  Although  higher  FSE
as  found  to  improve  visual  performance,  reversal  effect  if
ny  with  higher  FSE  must  be  evaluated  cautiously  while  pre-
cribing.  Quantitative  measurements  of  visual  disturbances
xperienced  by  the  subject  would  be  beneﬁcial  while  pre-
cribing  the  device.
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